Publications by authors named "Ralf Wilkowski"

Claim this Profile
F
Feasibility and effects of high-dose hypofractionated radiation therapy and simultaneous multi-kinase inhibition with sunitinib in progressive metastatic renal cell cancer.
Michael Staehler, Nicolas Haseke, Thomas Stadler, Philipp Nuhn, Alexander Roosen, Ralf Wilkowski

Urol Oncol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surveillance of megakaryocytic function by measurement of CD61-exposing microparticles in allogeneic hematopoietic stem cell recipients.
Andreas Rank, Rienk Nieuwland, Ruth Delker, Verena Pihusch, Ralf Wilkowski

Clin Transplant· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular origin of platelet-derived microparticles in vivo.
Andreas Rank, Rienk Nieuwland, Ruth Delker, Anton Köhler, Bettina Toth, Ralf Wilkowski

Thromb Res· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic relevance of CA 19-9, CEA, CRP, and LDH kinetics in patients treated with palliative second-line therapy for advanced pancreatic cancer.
Michael Haas, Rüdiger P Laubender, Petra Stieber, Stefan Holdenrieder, Christiane J Bruns, Ralf Wilkowski

Tumour Biol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of a time-varying covariate model to the analysis of CA 19-9 as serum biomarker in patients with advanced pancreatic cancer.
Stefan Boeck, Michael Haas, Rüdiger P Laubender, Frank Kullmann, Christina Klose, Ralf Wilkowski

Clin Cancer Res· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical relevance of circulating nucleosomes in cancer.
Stefan Holdenrieder, Dorothea Nagel, Andreas Schalhorn, Volker Heinemann, Ralf Wilkowski

Ann N Y Acad Sci· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral capecitabine in gemcitabine-pretreated patients with advanced pancreatic cancer.
Stefan Boeck, Ralf Wilkowski, Christiane J Bruns, Rolf D Issels, Christoph Schulz

Oncology· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiochemotherapy in combination with regional hyperthermia in preirradiated patients with recurrent rectal cancer.
Valeria Milani, Montserrat Pazos, Rolf Dieter Issels, Veit Buecklein, Sultan Rahman, Ralf Wilkowski

Strahlenther Onkol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiangiogenic therapy with mammalian target of rapamycin inhibitor RAD001 (Everolimus) increases radiosensitivity in solid cancer.
Philipp C Manegold, Carmen Paringer, Ulrike Kulka, Klaus Krimmel, Martin E Eichhorn, Ralf Wilkowski

Clin Cancer Res· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Importance of performance status for treatment outcome in advanced pancreatic cancer.
Stefan Boeck, Axel Hinke, Ralf Wilkowski, Volker Heinemann

World J Gastroenterol· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic and therapeutic significance of carbohydrate antigen 19-9 as tumor marker in patients with pancreatic cancer.
Stefan Boeck, Petra Stieber, Stefan Holdenrieder, Ralf Wilkowski, Volker Heinemann

Oncology· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of photofrin II as a radiosensitizing agent in solid tumors--preliminary results.
Moshe Schaffer, Birgit Ertl-Wagner, Pamela Manuela Schaffer, Ulrike Kulka, Giulio Jori, Ralf Wilkowski

Onkologie· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nucleosomes in colorectal cancer patients during radiochemotherapy.
Andreas Kremer, Stefan Holdenrieder, Petra Stieber, Ralf Wilkowski, Dorothea Nagel

Tumour Biol· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase III trial of gemcitabine plus cisplatin compared with gemcitabine alone in advanced pancreatic cancer.
Volker Heinemann, Detlef Quietzsch, Frank Gieseler, Michael Gonnermann, Herbert Schönekäs, Ralf Wilkowski

J Clin Oncol· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemoradiotherapy with gemcitabine and continuous 5-FU in patients with primary inoperable pancreatic cancer.
Ralf Wilkowski, Martin Thoma, Christiane Bruns, Andreas Wagner, Volker Heinemann

JOP· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined chemoradiotherapy for isolated local recurrence after primary resection of pancreatic cancer.
Ralf Wilkowski, Martin Thoma, Christiane Bruns, Eckhard Dühmke, Volker Heinemann

JOP· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new concurrent chemotherapy with vinorelbine and mitomycin C in combination with radiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck.
Ralf Wilkowski, Sophia Pachmann, Beatrice Schymura, Marc Dellian, Andreas Schalhorn

Onkologie· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemoradiation for ductal pancreatic carcinoma: principles of combining chemotherapy with radiation, definition of target volume and radiation dose.
Ralf Wilkowski, Martin Thoma, Helmut Weingandt, Eckhart Dühmke, Volker Heinemann

JOP· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nucleosomes in pancreatic cancer patients during radiochemotherapy.
Andreas Kremer, Ralf Wilkowski, Stefan Holdenrieder, Dorothea Nagel, Petra Stieber

Tumour Biol· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of chemoradiotherapy with gemcitabine and cisplatin on locoregional control in patients with primary inoperable pancreatic cancer.
Ralf Wilkowski, Martin Thoma, Rolf Schauer, Andreas Wagner, Volker Heinemann

World J Surg· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concurrent chemoradiotherapy with gemcitabine and cisplatin after incomplete (R1) resection of locally advanced pancreatic carcinoma.
Ralf Wilkowski, Martin Thoma, Eckhart Dühmke, Horst Günter Rau, Volker Heinemann

Int J Radiat Oncol Biol Phys· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detrimental immunologic effects of preoperative chemoradiotherapy in advanced rectal cancer.
Matthias W Wichmann, Günther Meyer, Michaela Adam, Wilma Höchtlen-Vollmar, Martin K Angele, Ralf Wilkowski

Dis Colon Rectum· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Radiochemotherapy with gemcitabine and cisplatin in pancreatic cancer -- feasible and effective].
Ralf Wilkowski, Martin Thoma, Volker Heinemann, Horst-Günter Rau, Andreas Wagner

Strahlenther Onkol· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis